Corrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1".
Hai-Han LiaoJin-Xiu ZhuHong FengJian NiNan ZhangSi ChenHuang-Jun LiuZheng YangDeng WeiQi-Zhu TangPublished in: Oxidative medicine and cellular longevity (2021)
[This corrects the article DOI: 10.1155/2017/8370593.].